Skip to content
10-Q

Quarterly Report

REMEDENT, INC.

0001144204-17-043205

← back to feed
Filed
Aug 14, 2017 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2018 · Aug 14, 2017 20M sh
Stockholders Equity Q1 2018 · Jun 30, 2017 $3.17M
Stockholders Equity Q1 2018 · Mar 31, 2017 $3.11M
Current Liabilities Q1 2018 · Jun 30, 2017 $1.47M
Current Liabilities Q1 2018 · Mar 31, 2017 $1.55M
Current Assets Q1 2018 · Jun 30, 2017 $1.24M
Current Assets Q1 2018 · Mar 31, 2017 $1.28M
Total Assets Q1 2018 · Jun 30, 2017 $4.71M
Total Assets Q1 2018 · Mar 31, 2017 $4.73M
Shares Diluted Q1 2018 · Jun 30, 2016 20M sh
Cash And Equivalents Q1 2018 · Jun 30, 2016 $107.16K
Cash And Equivalents Q1 2018 · Mar 31, 2016 $94.43K
Eps Diluted Q1 2018 · Jun 30, 2016 $0.01
Eps Basic Q1 2018 · Jun 30, 2016 $0.01
Sga Expense Q1 2018 · Jun 30, 2016 $218.92K
Rd Expense Q1 2018 · Jun 30, 2016 $7.69K
Operating Income Q1 2018 · Jun 30, 2016 $3.24K
Gross Profit Q1 2018 · Jun 30, 2016 $425.62K